Fresenius | FRE - Ebit

Aktienkurs
43.69
Täglich Wechseln
-0.81 -1.82%
Monatlich
-15.53%
Jährlich
11.14%
Q1 Prognose
42.44




Ebit Veränderung Datum
Akzo Nobel EUR 217M 80M 2025-12
Alcon AG USD 317M 17M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BASF EUR -175M 668M 2025-12
Bayer EUR 1.11B 1.51B 2025-12
Beiersdorf EUR 504M 312M 2025-12
DaVita Healthcare Partners USD 584.2M 124.84M 2025-12
Demant DKK 2.07B 201M 2025-12
E.ON EUR 1.06B 349M 2025-12
Essilor EUR 1.38B 626M 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 663M 213.06M 2025-12
Getinge SEK 2.02B 1.2B 2024-12
Givaudan CHF 610M 149M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
GN Store Nord DKK 570M 230M 2025-12
GRIFOLS EUR 352.11M 20.18M 2025-09
Hikma Pharmaceutical USD 348M 31M 2025-12
Lonza CHF 673M 54M 2025-06
Merck EUR 474M 738M 2025-12
Novartis USD 4.06B 530M 2025-12
Philips EUR 719M 390M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
RWE EUR 577M 851M 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Smith & Nephew USD 440M 50M 2025-12